Vanberra Signal

MolecularMatch

Curated by Signal

Provider of Saas-based platform for clinical trials and personalized medicines

Overview

Provider of Saas-based platform for clinical trials and personalized medicines. It helps patients find the best-personalized medicine based on the unique genetic signature of their disease. Also allows them to directly request enrollment in clinical trials anywhere in the world for targeted drug development. The clinical trial database is free for users. Also offers pharmacogenomics software meant specifically for pathology labs.

Key facts

Founded
2014

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Digital Pathology for clinical diagnostics and drug discovery

    Life Sciences TechnologySunnyvale, United States
  • Imaging supplies and accessories for radiology suites

    Life Sciences TechnologyCaledonia, United States
  • Developer of ECG devices and cardiac health monitoring tools

    Life Sciences TechnologyTorrance, United States

About MolecularMatch

What does MolecularMatch do?

Provider of Saas-based platform for clinical trials and personalized medicines.

Where is MolecularMatch headquartered?

MolecularMatch is headquartered in Houston, United States.

When was MolecularMatch founded?

MolecularMatch was founded in 2014.

Which sector is MolecularMatch in?

MolecularMatch operates in Life Sciences Technology.

Who are MolecularMatch's competitors?

Companies similar to MolecularMatch include BioImagene, Cone Instruments, and QT Medical.